Here, we present data showing increased expression of IL-32 and CCL20 in patients with MASH, as well as their induction by PA in hepatoma cells, likely mediated by oxidative stress and cellular lipid loading. The gene discussed is IL32; the disease is hepatocellular carcinoma.